The president who ran on his business acumen isn’t holding back in telling corporate bosses how to run their companies—or ...

Medtronic announced a spin-off of its diabetes business in May, which will be completed in 2026. Read more on MDT stock here.

Although the company's advancements have influenced contemporary healthcare, its stock presents a more cautious narrative ...

While Medtronic has struggled to keep up with the broader market over the past year, analysts remain fairly upbeat on its ...

Tandem (TNDM) stock falls and Insulet (PODD) stock gains as investors react to the companies' Q2 2025 results and guidance.

In a pooled analysis of three randomized trials, CPAP had overall null cardiovascular effects in patients with obstructive ...

Medtronic's separation of its Medtronic Diabetes unit into a publicly traded company named MiniMed will be a new beginning ...

Medtronic also disclosed severance for a former SVP, and pay for its median employee, and a slight decrease in global ...

Orchestra BioMed reported that it has secured over $111 million in financing through a series of transactions and ...

Medtronic has long been a committed dividend payer -- and grower. It's been turning itself around after a slump. There's ...

Medtronic Diabetes today offered a sneak peek at the new Abbott sensor technology specifically designed for its MiniMed ...

Orchestra BioMed announced today that it completed strategic transactions and equity offerings worth an expected $111.2 ...